Copyright: ©Author(s) 2026.
World J Hepatol. May 27, 2026; 18(5): 119408
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.119408
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.119408
Table 2 Risk of assessment of included studies using the Quality in Prognosis Studies tool
| Ref. | Study participation | Study attrition | Prognostic factor measurement | Outcome measurement | Confounding | Statistical analysis and statistical reporting |
| Azer et al[9] | Low | Low | Moderate | Low | High | Moderate |
| Janssen et al[10] | Low | Low | Low | Low | High | Moderate |
| Sundararajan et al[11] | Low | Low | Moderate | Low | High | Moderate |
| Muraca et al[12] | Low | Low | Low | Low | High | Moderate |
| Wu et al[14] | Low | Low | Low | Low | Low | Low |
- Citation: Gadour E, Kuriry H, Miutescu B, Raheem B, Gardezi SA, AlQahtani MS. Diagnostic and prognostic utility of serum bile acid in liver transplant recipients: A systematic review and quantitative synthesis. World J Hepatol 2026; 18(5): 119408
- URL: https://www.wjgnet.com/1948-5182/full/v18/i5/119408.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i5.119408